Geometry Dash APK Hill Climb Racing APK
62.7 F
New York
Monday, May 29, 2023

Enzolytics Inc (OTCMKTS:ENZC) Continues to Move Higher On Massive Volume

Must read

Asia Broadband Inc (OTCMKTS:AABB) Is Up 1100% This year: What’s The Buzz?

There are some stocks that have managed to clock massive over the course of the past month or so and one of...

Blockchain Technologies Ltd (OTCMKTS:HVBTF) Makes A Stunning Move on Blockchain Optimism

The cryptocurrency boom has sustained for many months now and it anything; it is expected to continue in the future.

Bombardier, Inc. (OTCMKTS:BDRBF) Continues to Gain Momentum and Strength

Many stocks have managed to record significant gains in recent months and one that often flies under the radar is Bombardier,...

Grayscale Bitcoin Trust (Btc) (GBTC) Makes Big Move As Bitcoin Goes Wild

Bitcoin, the world’s biggest cryptocurrency by market cap, has been in the middle of a remarkable rally for the past few months...

Companies that are working on ways to tackle HIV are almost always an attractive proposition for investors, especially if the companies in question show some progress.

One such company could be Enzolytics Inc (OTCMKTS:ENZC) and in recent days, its stock has also performed impressively.

Key Triggers

Following an announcement from the company on Monday, the Enzolytics stock rallied strongly and went up by as much as 28% yesterday. The latest rally in Enzolytics Inc (OTCMKTS:ENZC) took its gains over the course of the past month to as much as 300%.

The rally experienced by the stock this week was linked to an announcement made by the company with regards to the latest discovery.

Enzolytics announced on February 1 that it managed to identify as many as seven new conserved and possibly immutable sites on the HIV virus. However, that is not all. The company also announced that it is now aiming to come up with anti-HIV monoclonal antibodies that are meant for specifically targeting those sites.

It is a major development for the company and it was no surprise that the news was welcomed with such optimism by investors. At this point in time, the anti-HIV monoclonal antibody from Enzolytics can target only one such site.

The discovery of new sites is a welcome development since the company is now going to start working on producing anti-HIV monoclonal antibodies Institute for Preclinical Studies at Texas A&M University. However, that is not all.

Last month, Enzolytics announced that it got the official filing receipt from the United States Patent Office with regards to its multiple sclerosis patent application.

The application in question is titled “Nuclear Proteins Isolated from Mammalian Spinal Cord Immune Factor – Pharmaceutical Composition for Treatment”. More importantly, it is necessary to point out that Enzolytics also received the third tranche of financing worth as much as $1.2 million.

Disclaimer: We hold no position in ENZC stock

Latest article

Alibaba Group Holding Limited (OTCMKTS:BABAF) Big Volume with Possible 60% Upside

Alibaba Group Holding Limited (OTCMKTS:  BABAF) is an over the counter stock traded on the OTC Pink markets in the Consumer Discretionary...

Trans Global Group Inc (OTCMKTS:TGGI) Stock In Focus After Operational Updates

The Trans Global Group Inc (OTCMKTS:TGGI) stock may not have been in the news today yet but it...

Why Hycroft Mining (NASDAQ:HYMC) Stock Shot Up 700%

If you are on the hunt for stocks that may have made major gains over the course of the past week, then...

Secure Paymentz releases banking software demo on Github

This is a paid announcement from one of our advertising partners. How to Leverage Your Trading Position by Secure...

Advanced Asset Management Announces New Website Launch

This is a paid announcement from one of our advertising partners. Financial Planner in Grandville, Michigan
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service